Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-30EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changesbioRxiv · 2026-06-11Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-04Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-02Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.Unknown journal · 2026-05-28Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.Open Access CRIS of the University of Bern · 2026-05-27Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman SpectroscopyJournal of Raman Spectroscopy · 2026-05-27Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.Unknown journal · 2026-05-24Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical TrialClinicalTrials.gov · 2026-05-17Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-11Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot StudyClinicalTrials.gov · 2026-05-05Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBSGastrointestinal Endoscopy · 2026-04-30157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium DynamicsBiological Psychiatry · 2026-04-24356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-04-24483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-AnalysisBiological Psychiatry · 2026-04-24Methamphetamine-Fentanyl Polysubstance Administration Produces Social Deficits and Corticolimbic Stress-Reward Circuit AdaptationsResearch Square · 2026-04-22Psilocybin’s Kinematic Effect on Manual DexterityResearch Square · 2026-04-14A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-13Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-12An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive DisorderClinical Neuropharmacology · 2026-03-31MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More!Psychiatric News · 2026-03-29The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22Psilocybin effects on brain functional connectivity: a systematic review of fMRI studiesDiscover Mental Health · 2026-03-18Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-18Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-03-17Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.Unknown journal · 2026-02-27MedCheck: FDA Reviews NDA for Narcolepsy Drug, Green-Lights Psilocybin Trial for PTSD, and MorePsychiatric News · 2026-02-25Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25Cogumelos do gênero Psilocybe nas Américas e no BrasilAnthropology of Consciousness · 2026-02-21Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trialBJPsych Open · 2026-02-15Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-02-15Psilocybin and Animal Testing: Charting an End to the Use of Animals in Drug Development ResearchDigital Commons at University of Maryland Carey Law (University of Maryland Francis King Carey School of Law) · 2026-02-11Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effectsEuropean Archives of Psychiatry and Clinical Neuroscience · 2026-02-11Acute psilocin increased cortical activity in ratFrontiers in Neuroscience · 2026-02-03Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot StudyPsychedelic Medicine · 2026-02-02The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative ReviewCureus · 2026-01-30Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experienceJournal of Psychopharmacology · 2026-01-25Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybinJournal of Clinical Epidemiology · 2026-01-22Systematic study of Panaeolus (Agaricales, Galeropsidaceae) sensu lato and psilocybin-producing traits of species from ChinaIMA Fungus · 2026-01-18Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-17The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?Psychiatric Research and Clinical Practice · 2026-01-13Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted TherapyPsychedelic Medicine · 2026-01-11An open-label pilot study of psilocybin-assisted therapy for binge eating disorderJournal of Eating Disorders · 2026-01-02The one that abstained: Psilocybe fuscofulva genome suggests two recent origins of the psilocybin gene cluster in PsilocybebioRxiv · 2026-01-01Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2026-01-01Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and PsilocybinHuman Psychopharmacology Clinical and Experimental · 2025-12-31Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortexNeurotherapeutics · 2025-12-31Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure RisksUnknown journal · 2025-12-28A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use DisorderPsychedelic Medicine · 2025-12-25Evolution and horizontal transfer of the psilocybin biosynthetic gene cluster drive the diversification of magic mushroomsMycosphere · 2025-12-24Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 StudyPsychedelic Medicine · 2025-12-22The genus Psilocybe in ItalyItalian Botanist · 2025-12-21Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-18Wherefore the magic? The evolutionary role of psilocybin in naturebioRxiv · 2025-12-18Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot studyBJPsych Open · 2025-12-14The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin ExperienceJournal of Clinical Psychopharmacology · 2025-12-08Efficacy of psilocybin on death anxiety in terminal patients: a narrative reviewProgress in Palliative Care · 2025-11-30Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging studyUnknown journal · 2025-11-30Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvementResearch Square · 2025-11-30Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in SwitzerlandmedRxiv · 2025-11-30Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentEClinicalMedicine · 2025-11-30Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.Unknown journal · 2025-11-06Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocinMetabolic Engineering · 2025-11-04Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacyBMJ Supportive & Palliative Care · 2025-11-02The emotional architecture of the psychedelic brain.Trends in cognitive sciences · 2025-10-31Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic reviewBJPsych Open · 2025-10-31Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trialPilot and Feasibility Studies · 2025-10-27Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depressionGeneral Hospital Psychiatry · 2025-10-10Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behaviorbioRxiv · 2025-09-30Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspringNature Communications · 2025-09-29Regional Specificity of the Cingulate Cortex Thickness Association with the Intensity of Psilocybin Experience: A Replication StudyResearch Square · 2025-09-24Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on AlcoholismClinicalTrials.gov · 2025-09-23Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility studyAddiction · 2025-09-19S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the USJournal of Clinical Medicine · 2025-09-18PRoMiSS: Psilocybin and the Role of Music in Set and SettingClinicalTrials.gov · 2025-09-17Dynamic myocardial injury and variable hallucination latency in Psilocybe keralensis poisoning: a molecularly confirmed case series from ChinaClinical Toxicology · 2025-09-14Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted TherapyHealthcare · 2025-09-11Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Unknown journal · 2025-09-06Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case ReportPsychoactives · 2025-08-31Psilocybin Use in the Autism Spectrum Disorder: A Scoping ReviewClinical Neuropharmacology · 2025-08-31US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022Journal of the American College of Emergency Physicians Open · 2025-08-29Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysisTranslational Psychiatry · 2025-08-28Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trialJournal of Psychopharmacology · 2025-08-28Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybinMolecular Psychiatry · 2025-08-25“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-24Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorderNeuropharmacology · 2025-08-20Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications.ACS chemical neuroscience · 2025-08-05A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy.Unknown journal · 2025-08-04Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation RetreatmedRxiv · 2025-07-29“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smokeAddiction Science & Clinical Practice · 2025-07-20Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot studyJournal of Vision · 2025-07-14Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic MicePharmaceuticals · 2025-07-05Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use DisorderPsyArXiv · 2025-06-09Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.Unknown journal · 2025-06-07Psilocybin With Intracranial Neural SensingClinicalTrials.gov · 2025-06-05Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybinbioRxiv · 2025-05-29Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosaJournal of Eating Disorders · 2025-05-25Role of endogenous serotonin in psychedelic-like effects of psilocybin in miceThe International Journal of Neuropsychopharmacology · 2025-05-24Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J micePsychopharmacology · 2025-05-15A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.Unknown journal · 2025-05-05The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.Neuroscience and biobehavioral reviews · 2025-04-30Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.Journal of psychoactive drugs · 2025-04-24Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2025-04-21Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative CarePalliative Medicine Reports · 2025-04-16Psilocybin biosynthesis enhancement through gene source optimizationMetabolic Engineering · 2025-04-15The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingClinicalTrials.gov · 2025-04-1358. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-0813. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-08Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trialNeuropsychopharmacology · 2025-04-08Therapeutic Potential of Psilocybin-Assisted Therapy in Hospice and Palliative CareRevista Cacto - Ciência Arte Comunicação em Transdisciplinaridade Online · 2025-04-02Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.Unknown journal · 2025-04-01Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptorsNature · 2025-04-01LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in MicePharmaceuticals · 2025-03-22Structural basis for psilocybin biosynthesisNature Communications · 2025-03-21Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic PropertiesJournal of Medicinal Chemistry · 2025-03-19Psilocybin for disorders of consciousness: A case-report studyClinical Neurophysiology · 2025-03-07Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond.Unknown journal · 2025-03-06Risks of using psilocybin in treatment of treatment-resistant depressionJournal of Education Health and Sport · 2025-03-05Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.Unknown journal · 2025-02-28A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.Unknown journal · 2025-02-23Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.Unknown journal · 2025-02-17Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländernedoc Publication server (Humboldt University of Berlin) · 2025-02-11Psilocybin alters visual contextual computationsbioRxiv · 2025-02-07Prevalence of Use of Psilocybin and MDMA in Multiple US CitiesDrug and Alcohol Dependence · 2025-01-31Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?Journal of Psychedelic Studies · 2025-01-20What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?Cochrane Clinical Answers · 2025-01-12A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy · 2025-01-12Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health ConditionsAmerican Journal of Psychiatry · 2024-12-31Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ ConcernsThe Journal of Law Medicine & Ethics · 2024-12-31High-quality draft genomes of ecologically and geographically diverse Psilocybe speciesMicrobiology Resource Announcements · 2024-12-26The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.Unknown journal · 2024-11-30Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.Unknown journal · 2024-11-26Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trialJournal of Vision · 2024-11-04Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experienceBJPsych Open · 2024-10-31Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical modelsBrain Behavior and Immunity · 2024-10-31Optimized psilocybin production in tryptophan catabolism-repressed fungiMicrobial Biotechnology · 2024-10-31Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experienceBJPsych Open · 2024-10-31Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent MannerMolecules · 2024-10-27The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depressionJournal of Psychiatric Research · 2024-10-10Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-08What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative studyPalliative & Supportive Care · 2024-09-30Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorderPsychedelics. · 2024-09-23Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humansmedRxiv · 2024-09-21Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-09-19B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult PopulationsArchives of Clinical Neuropsychology · 2024-09-11Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.Unknown journal · 2024-09-11Usage of Psilocybin to Treat Huntington's Disease: A Research ProtocolUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2024-09-04Refractory CRPS pain treated with psilocybin: A case reportClinical Case Reports · 2024-08-31Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction RelapseThe Journal of Clinical Psychiatry · 2024-08-24A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-18Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-23Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionTrials · 2024-07-02Effects of psilocybin on body weight, body composition, and metabolites in male and female micePhysiology & Behavior · 2024-07-01Regional Differences of Self-Reported Past-12-month Marijuana, Psilocybin, and Cocaine Use: Results From NDEWS Rapid Street Reporting 2021-2022Drug and Alcohol Dependence · 2024-06-30Treating Anxiety and Depression With Psilocybin Therapy.PubMed · 2024-06-30Effects of psilocybin on uncertain punishment learningNeurobiology of Learning and Memory · 2024-06-21Comparing Cannabis Use Motivations and Dependence Across Regular Cannabis Users Who Have or Have Not Recently Used PsilocybinCannabis and Cannabinoid Research · 2024-06-16Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research ProtocolUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2024-06-09WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male miceJournal of Hepatology · 2024-05-31Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.Journal of Clinical Oncology · 2024-05-31Long-COVID symptoms improved after MDMA and psilocybin therapy: A case reportClinical Case Reports · 2024-05-27A Case Report of Psilocybin-induced Psychosis in a Predisposed PatientClinical Psychopharmacology and Neuroscience · 2024-05-20Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.Psychiatry research · 2024-04-30In vitro and in vivo metabolism of psilocybin’s active metabolite psilocinFrontiers in Pharmacology · 2024-04-28Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.Unknown journal · 2024-04-22Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distressFrontiers in Psychiatry · 2024-04-17Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationScientific Reports · 2024-03-25Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022Drug and Alcohol Dependence · 2024-02-05Psilocybin and eugenol prevent DSS-induced neuroinflammation in miceBiocatalysis and Agricultural Biotechnology · 2024-01-24Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based surveyPalliative Medicine · 2024-01-21Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.Unknown journal · 2024-01-19Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patientsNeuroscience Applied · 2023-12-31Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapyNeuroscience Applied · 2023-12-31Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental DisordersAnnals of Bioethics & Clinical Applications · 2023-12-31Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledgeJournal of Education Health and Sport · 2023-12-29Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depressionResearch Square · 2023-12-27Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.ClinicalTrials.gov · 2023-12-25Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysisCancer · 2023-12-17The psychedelic effects of cannabis: A review of the literature.Unknown journal · 2023-11-09Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesionsEuropean Archives of Psychiatry and Clinical Neuroscience · 2023-11-06Cultivation, chemistry, and genome of Psilocybe zapotecorumbioRxiv · 2023-11-01Anxiolytic behavior accompanied by the alteration of the intestinal bacteriome during psilocybin treatmentBrain Behavior and Immunity · 2023-10-31Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.Unknown journal · 2023-10-31A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issuesPsyArXiv · 2023-10-26Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.Unknown journal · 2023-10-04Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorderFrontiers in Psychiatry · 2023-09-17Can a single dose of psilocybin improve cognitive control in functional dissociative seizures?Medical Hypotheses · 2023-09-08Rapid, biochemical tagging of cellular activity history in vivobioRxiv · 2023-09-07